PE4696A1 - Agente hipocolesterolemico - Google Patents

Agente hipocolesterolemico

Info

Publication number
PE4696A1
PE4696A1 PE1994257662A PE25766294A PE4696A1 PE 4696 A1 PE4696 A1 PE 4696A1 PE 1994257662 A PE1994257662 A PE 1994257662A PE 25766294 A PE25766294 A PE 25766294A PE 4696 A1 PE4696 A1 PE 4696A1
Authority
PE
Peru
Prior art keywords
alkyl
alcoxi
choh
carbonyl
cycloalkyl
Prior art date
Application number
PE1994257662A
Other languages
English (en)
Inventor
Michael Paul Deninno
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PE4696A1 publication Critical patent/PE4696A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A UN GLICOSIDO ESTEROIDAL DERIVADO DE ESPIROSTANILO DE FORMULA I DONDE: 1) Q1 ES CARBONILO, -CHOH-; 2) Q2 ES METILENO, CARBONILO, -CHOH-; 3) R1, R2, R3 SON HIDROGENO, HIDROXI, HALO, AMINO, AZIDO, ALCOXI C1-C6 UNIDO A ALCOXI C1-C6 o -Z-R4, 4) Z ES -NH-CO-, -O-CO-, -O-CO-NR5, -NH-CO-NR5- o -O-CS-NR5-; 5) R4 ES ARILO, ARILOALQUILO C1-C6, ALQUENILO C2-C4, ALQUILO C1-C6, CICLOALQUILO C3-C7 o CICLOALQUILO C3-C7 UNIDO A UN ALQUILO C1-C6; CADA R4 OPCIONALMENTE MONO, DI O TRISUSTITUIDO, R4 PUEDE SER: FENILO, 2,4-DIFLUOROFENILO, 2-FLUOROFENILO, 2-METILFENILO, Y OTROS; 6) R5 ES HIDROGENO, ALQUILO DE (C1-C4) o R5 CUANDO SE TOMA JUNTO CON EL NITROGENO AL QUE ESTA UNIDO Y CON R4, DONDE R4 ES UN ENLACE COVALENTE, FORMA UN ANILLO TAL COMO: PIRROLIDINILO, PIPERIDINILO, N-METILPIPERACINILO, INDOLINILO o MORFOLILO; DICHO COMPUESTO PUEDE INHIBIR LA ABSORCION DE COLESTEROL Y SER UTIL EN EL CONTROL DE HIPERCOLESTEROLEMIA Y ATEROSCLEROSIS
PE1994257662A 1993-12-28 1994-12-22 Agente hipocolesterolemico PE4696A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17409993A 1993-12-28 1993-12-28

Publications (1)

Publication Number Publication Date
PE4696A1 true PE4696A1 (es) 1996-03-09

Family

ID=22634815

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1994257662A PE4696A1 (es) 1993-12-28 1994-12-22 Agente hipocolesterolemico

Country Status (11)

Country Link
US (1) US5939398A (es)
EP (1) EP0737202A1 (es)
JP (1) JPH09500906A (es)
AU (1) AU7948394A (es)
CA (1) CA2180148A1 (es)
CO (1) CO4230020A1 (es)
FI (1) FI946105A (es)
IL (1) IL112115A0 (es)
MA (1) MA23411A1 (es)
PE (1) PE4696A1 (es)
WO (1) WO1995018143A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698527A (en) * 1995-08-08 1997-12-16 Merck & Co., Inc. Steroidal glycosides as antihyperlipidemic agents
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
PL195897B1 (pl) * 1998-03-26 2007-11-30 Phytopharm Plc Zastosowanie smilageniny
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives
EP1558627B1 (en) 2002-10-28 2010-03-03 Phytopharm Plc Stereospecific reduction of sapogen-3-ones

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia
CA2123684A1 (en) * 1991-11-25 1993-06-10 Douglas J. M. Allen Method for making steroidal peracyl glycosides
CA2138016A1 (en) * 1992-06-26 1994-01-06 Kathleen D. Goggin Steroidal beta-o-cellobioside heptaalkanoate process
AU4226593A (en) * 1992-06-26 1994-01-24 Pfizer Inc. Steroidal glycosides for treating hypercholesterolemia
MX9702175A (es) * 1994-09-20 1997-06-28 Pfizer Combinacion de un inhibidor de absorcion de colesterol y un inhibidor de sintesis de colesterol.

Also Published As

Publication number Publication date
IL112115A0 (en) 1995-03-15
EP0737202A1 (en) 1996-10-16
WO1995018143A1 (en) 1995-07-06
FI946105A0 (fi) 1994-12-27
US5939398A (en) 1999-08-17
CA2180148A1 (en) 1995-07-06
MA23411A1 (fr) 1995-07-01
AU7948394A (en) 1995-07-17
CO4230020A1 (es) 1995-10-19
FI946105A (fi) 1995-06-29
JPH09500906A (ja) 1997-01-28

Similar Documents

Publication Publication Date Title
PE4696A1 (es) Agente hipocolesterolemico
PE49295A1 (es) Glicosido esteroideo derivado de espirostanilo
ES2163004T3 (es) Feniloxazolidinona sustituida por un anillo heteroaromatico como agente antimicrobiano.
LV12618A (en) Use of sulphamate derivatives as steroid sulphatase inhibitors
TW351668B (en) Oxymethoxy-3-aryl-pyrone derivatives, their preparation, their use for controlling pest and pesticides containing the same
ES2233479T3 (es) Derivados de triazaespiro (5,5) undecano y composiciones farmaceuticas que los comprenden, como ingrediente activo.
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
CY1108850T1 (el) ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΠΕΡΙΛΑΜΒΑΝΟΥΝ ΠΑΡΑΓΩΓΑ ΠΥΡΡΟΛΟ[2,3-d] ΠΥΡΙΜΙΔΙΝΗΣ
SI1534678T1 (sl) Plevromutilinski derivati kot antimikrobna sredstva
BR9803301A (pt) Processo para a produção de espuma de poliuretano, espuma de poliuretano, painel de isolamento evacuado, unidade de isolamento térmico, e, composição reativa a isocianato.
PE20060455A1 (es) Nucleosidos de 3-beta-d-ribofuranosiltiazolo[4,5-d]pirimidina
MX9602850A (es) Derivados de pirrolopiridazina.
NO961693L (no) Delta16-umettede C17-heterocykliske steroider som er anvendbare som steroid C17-20-lyaseinhibitorer
CA2330007A1 (en) Improvements in macrolide production
GR3027788T3 (en) Process for preparing beta-lactam derivative and synthetic intermediate thereof
GB9325415D0 (en) Chemical compounds
DE59806541D1 (de) Verwendung von alkoholen als additive für putze und/oder mörtel
ES2171943T3 (es) Nuevo procedimiento de isomerizacion del radical metilo en posicion 10 de derivados de eritromicina.
DK0973782T3 (da) Isocyanater, der er modificeret med henhblik på at bibringe dem en overfladeaktiv egenskab, sammensætning indeholdende disse samt resulterende belægning
PE60096A1 (es) Inhibidor de la escualeno sintetasa
DK0688212T3 (da) C9-taxanderivater og farmaceutiske præparater indeholdende disse
DK0758340T3 (da) Fremgangsmåde til fremstilling af 4-amino-delta 4-3-ketosteroider via 4-nitro-delta 4-3-ketosteroider
DK1322660T3 (da) 17a-fluoralkylsteroider, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder disse forbindelser
MY122562A (en) Antibacterial composition
PE20020752A1 (es) Esteroides con doble enlace delta 14 sustituido en las posiciones 13 y 14 con actividad androgenica y progestagena

Legal Events

Date Code Title Description
FA Abandonment or withdrawal